Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -W-
06.02.2024 23:26:52

Gilead Sciences Inc. Q4 Profit Decreases, misses estimates

(RTTNews) - Gilead Sciences Inc. (GILD) released earnings for fourth quarter that decreased from the same period last year and missed the Street estimates.

The company's earnings came in at $1.43 billion, or $1.14 per share. This compares with $1.64 billion, or $1.30 per share, in last year's fourth quarter.

Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.16 billion or $1.72 per share for the period.

Analysts on average had expected the company to earn $1.76 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 3.7% to $7.12 billion from $7.39 billion last year.

Gilead Sciences Inc. earnings at a glance (GAAP) :

-Earnings (Q4): $1.43 Bln. vs. $1.64 Bln. last year. -EPS (Q4): $1.14 vs. $1.30 last year. -Analyst Estimates: $1.76 -Revenue (Q4): $7.12 Bln vs. $7.39 Bln last year.

Analysen zu Gilead Sciences Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Gilead Sciences Inc. 83,75 -0,49% Gilead Sciences Inc.